These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28541590)

  • 41. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal denervation for resistant hypertension: acute results and long-term follow-up.
    Korovesis S; Giazitzoglou E; Pantos I; Tzanalaridou E; Kokladi M; Venetsanakos I; Paxinos G; Katritsis DG
    Hellenic J Cardiol; 2014; 55(3):211-6. PubMed ID: 24862613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.
    Yalagudri S; Raju N; Das B; Daware A; Maiya S; Jothiraj K; Ravikishore AG
    Indian Heart J; 2015; 67(3):207-13. PubMed ID: 26138176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH; Sayed MM; Reil JC; Lavall D; Ukena C; Linz D; Mahfoud F; Böhm M
    JACC Cardiovasc Interv; 2015 Jun; 8(7):972-80. PubMed ID: 26003031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J; Táborský M; Richter D
    Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure elevation response to radiofrequency energy delivery: one novel predictive marker to long-term success of renal denervation.
    Xu Y; Xiao P; Fan J; Chen W; Du H; Ling Z; Liu Z; Su L; Woo K; Yin Y
    J Hypertens; 2018 Dec; 36(12):2460-2470. PubMed ID: 30005028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
    EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
    de Leon-Martinez EP; Garza JA; Azpiri-Lopez JR; Dillon KN; Salazar LO; Canepa-Campos F; Rousselle SD; Tellez A
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):445-8. PubMed ID: 26014838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective proximal renal denervation guided by autonomic responses evoked via high-frequency stimulation in a preclinical canine model.
    Lu J; Wang Z; Zhou T; Chen S; Chen W; Du H; Tan Z; Yang H; Hu X; Liu C; Ling Z; Liu Z; Zrenner B; Woo K; Yin Y
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26058393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension].
    Zhao MM; Tan XX; Ding N; Zhang XL
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1234-7. PubMed ID: 23902614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.
    Lambert GW; Hering D; Esler MD; Marusic P; Lambert EA; Tanamas SK; Shaw J; Krum H; Dixon JB; Barton DA; Schlaich MP
    Hypertension; 2012 Dec; 60(6):1479-84. PubMed ID: 23071129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study.
    Miroslawska A; Solbu M; Skjølsvik E; Toft I; Steigen TK
    J Hum Hypertens; 2016 Mar; 30(3):153-7. PubMed ID: 26134621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [EFFICACY OF RADIOFREQUENCY ABLATION OF AORTORENAL SYMPATHETIC NODES IN PATIENTS IN ARTERIAL HYPERTENSION].
    Batsak BV; Gumenyuk BN; Trembovetskaya EM; Bespalova EY; Fanta SM
    Klin Khir; 2016 Mar; (3):41-2. PubMed ID: 27514092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM; Matchin IuG; Chazova IE
    Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of renal sympathetic denervation using saline-irrigated radiofrequency ablation catheter on the activity of the renin-angiotensin system and endothelin-1.
    Lu J; Ling Z; Chen W; Du H; Xu Y; Fan J; Long Y; Chen S; Xiao P; Liu Z; Zrenner B; Yin Y
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):532-9. PubMed ID: 24496516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
    Schlaich MP; Schmieder RE; Bakris G; Blankestijn PJ; Böhm M; Campese VM; Francis DP; Grassi G; Hering D; Katholi R; Kjeldsen S; Krum H; Mahfoud F; Mancia G; Messerli FH; Narkiewicz K; Parati G; Rocha-Singh KJ; Ruilope LM; Rump LC; Sica DA; Sobotka PA; Tsioufis C; Vonend O; Weber MA; Williams B; Zeller T; Esler MD
    J Am Coll Cardiol; 2013 Dec; 62(22):2031-45. PubMed ID: 24021387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.